HuGE Literature Finder
Records 1-30
|
Evaluation of breast screening strategies in a high risk breast and ovarian cancer clinic.
Gynecologic oncology reports 2020 Aug 33 100587. Knisely Anne T, Stewart Martha E, Garcia Christine, Thomas Martha H, Modesitt Susan C, Ring Kari |
|
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study.
Gynecologic oncology 2020 Jul . Lorusso D, Marchetti C, Conte C, Giudice E, Bolomini G, Vertechy L, Ceni V, Ditto A, Ferrandina G, Raspagliesi F, Scambia G, Fagotti |
|
Effects of BRCA gene mutation on female reproductive potential: A systematic review.
Maturitas 2020 Jul 137 11-17. Hu Kai-Lun, Wang Siwen, Ye Xiaohang, Zhang D |
|
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Jul . Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa |
|
Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Gynecologic oncology 2020 Jul . Weiss Arielle S, Swisher Elizabeth, Pennington Kathryn P, Radke Marc, Khasnavis Nithisha, Garcia Rochelle L, Kilgore Mark R, Lee Ming K, Norquist Barbara |
|
Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
|
3,3-Diindolylmethane (DIM): A nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial.
Carcinogenesis 2020 May . Yerushalmi Rinat, Bargil Sharon, Bar Yaara, Ozlavo Rachel, Tuval Sivan, Rapson Yael, Pomerantz Adi, Zoref Dalia, Sharon Eran, Caspi Opher, Grubsrein Ahuvah, Margel Dav |
|
BRCA Detection Rate in an Italian Cohort of Luminal Early-Onset and Triple-Negative Breast Cancer Patients without Family History: When Biology Overcomes Genealogy.
Cancers 2020 May 12 (5): . Toss Angela, Molinaro Eleonora, Venturelli Marta, Domati Federica, Marcheselli Luigi, Piana Simonetta, Barbieri Elena, Grandi Giovanni, Piombino Claudia, Marchi Isabella, Tenedini Elena, Tagliafico Enrico, Tazzioli Giovanni, Cortesi Lau |
|
Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2020 May . Algebaly A S, Suliman R S, Al-Qahtani W |
|
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Scientific reports 2020 Apr 10 (1): 7073. Talhouet Solene De, Peron Julien, Vuilleumier Aurelie, Friedlaender Alex, Viassolo Valeria, Ayme Aurélie, Bodmer Alexandre, Treilleux Isabelle, Lang Noemie, Tille Jean- Christophe, Chappuis Pierre O, Buisson Adrien, Giraud Sophie, Lasset Christine, Bonadona Valerie, Trédan Olivier, Labidi-Galy S Intidh |
|
Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
The British journal of surgery 2020 Apr . Cullinane C M, Creavin B, O'Connell E P, Kelly L, O'Sullivan M J, Corrigan M A, Redmond H |
|
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer.
BMC cancer 2020 Mar 20 (1): 185. Lee Yong Jae, Kim Hyun-Soo, Rim John Hoon, Lee Jung-Yun, Nam Eun Ji, Kim Sang Wun, Kim Sunghoon, Kim Young T |
|
Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
Aging 2020 Feb 12 . Chen Bo, Zhang Guochun, Li Xuerui, Ren Chongyang, Wang Yulei, Li Kai, Mok Hsiaopei, Cao Li, Wen Lingzhu, Jia Minghan, Li Cheukfai, Guo Liping, Wei Guangnan, Lin Jiali, Li Yingzi, Zhang Yuchen, Han-Zhang Han, Liu Jing, Lizaso Analyn, Liao Ni |
|
Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of 9 randomized controlled trials.
Bioscience reports 2020 Feb . Shao Fengping, Liu Jun, Duan Yaoyun, Li Li, Liu Liqun, Zhang Cai, He Shanya |
|
Frequency of BRCA1 and BRCA2 Mutations in Individuals with Breast and Ovarian Cancer in a Chinese Hakka Population Using Next-Generation Sequencing.
Human heredity 2020 Feb 1-10. Wu Heming, Wang Qiuming, Guo Xuemin, Liu Qinghua, Zhang Qunji, Huang Qingyan, Yu Zhika |
|
Germline mutation in 1,338 BRCA-negative Chinese hereditary breast and/or ovarian cancer patients: clinical testing with a multigene test panel.
The Journal of molecular diagnostics : JMD 2020 Feb . Kwong Ava, Shin Vivian Yvonne, Chen Jiawei, Wai-Yin Cheuk Isabella, Ho Cecilia Ys, Au Chun Hang, Chan Karen K L, Ngan Hextan Y S, Chan Tsun Leung, Ford James M, Ma Edmond |
|
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers.
The journal of pathology. Clinical research 2020 Feb . McCrorie Alan D, Ashfield Susannah, Begley Aislinn, Mcilmunn Colin, Morrison Patrick J, Boyd Clinton, Eccles Bryony, Greville-Heygate Stephanie, Copson Ellen R, Cutress Ramsey I, Eccles Diana M, Savage Kienan I, McIntosh Stuart |
|
BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database.
Oncology 2020 Jan 1-4. Blanter Julia, Zimmerman Brittney, Tharakan Serena, Ru Meng, Cascetta Krystal, Tiersten A |
|
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma.
Cancer research and treatment : official journal of Korean Cancer Association 2020 Jan . Choi Min Chul, Hwang Sohyun, Kim Sewha, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Tae-Heon, Kang Haeyoun, An Hee Ju |
|
Comparison of clinical features and oncologic outcomes between familial (non-hereditary) and hereditary breast cancer in Korean female patients.
Asian journal of surgery 2020 Jan . Park Chan Sub, Park Ho Yong, Jung Jin Hyang, Kim Wan Wook, Chae Yee Soo, Lee Soo Jung, Park Ji-Young, Park Jee Young, Lee Jeeye |
|
Inherited DNA-repair gene mutations in African American men with prostate cancer.
Oncotarget 2020 Jan 11 (4): 440-442. Sartor Oliver, Yang Shan, Ledet Elisa, Moses Marcus, Nicolosi Pip |
|
Multigene panel testing results in patients with multiple breast cancer primaries.
The breast journal 2020 Jan . Corredor Jessica, Woodson Ashley H, Gutierrez Barrera Angelica, Arun Ba |
|
Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.
Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
|
Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms.
Artificial cells, nanomedicine, and biotechnology 2019 Dec 47 (1): 1101-1112. Wang Le, Wang Hao, Wang Ting, Liu Jinhui, Chen Wei, Wang Yamin, Chen Chao, Zhu Hongli, Dai Pengg |
|
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.
Translational oncology 2019 Dec 13 (2): 212-220. Gallardo-Rincón Dolores, Álvarez-Gómez Rosa María, Montes-Servín Edgar, Toledo-Leyva Alfredo, Montes-Servín Elizabeth, Michel-Tello David, Alamilla-García Gabriela, Bahena-González Antonio, Hernández-Nava Elizabeth, Fragoso-Ontiveros Veronica, Espinosa-Romero Raquel, Cetina-Pérez Luce |
|
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Pancreatic Cancer Patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Dec . Goldstein Jennifer B, Zhao Li, Wang Xuemei, Ghelman Yael, Overman Michael J, Javle Milind, Shroff Rachna T, Varadhachary Gauri R, Wolf Robert A, McAllister Florencia, Futreal P Andrew, Fogelman David |
|
MUTATIONS OF GENES BRCA1 AND BRCA2 IN WOMEN WITH OVARIAN CANCER EXPOSED TO FACTORS OF CHORNOBYL NUCLEAR ACCIDENT.
Problemy radiatsiinoi medytsyny ta radiobiolohii 2019 Dec 24 455-464. Rybchenko L A, Poluben L O, Bychkova G M, Stephanovych G V, Klymenko S |
|
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
BMC cancer 2019 Nov 19 (1): 1145. Ruiz de Sabando Ainara, Urrutia Lafuente Edurne, García-Amigot Fermín, Alonso Sánchez Angel, Morales Garofalo Lourdes, Moreno Sira, Ardanaz Eva, Ramos-Arroyo Maria |
|
Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Scientific reports 2019 Nov 9 (1): 17769. Dutil Julie, Teer Jamie K, Golubeva Volha, Yoder Sean, Tong Wei Lue, Arroyo Nelly, Karam Rachid, Echenique Miguel, Matta Jaime L, Monteiro Alvaro |
|
Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
|
Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.
Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
|
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Gynecologic oncology 2019 Oct . Labidi-Galy S Intidhar, de La Motte Rouge Thibault, Derbel Olfa, Wolfer Anita, Kalbacher Elsa, Olivier Timothée, Combes Jean-Damien, Heimgartner-Hu Ketty, Tredan Olivier, Guevara Hemerson, Heudel Pierre-Etienne, Reverdy Thibaut, Bazan Fernando, Heinzelmann-Schwarz Viola, Fehr Mathias, de Castelbajac Victoire, Vaflard Pauline, Crivelli Louise, Bonadona Valerie, Viassolo Valeria, Buisson Adrien, Golmard Lisa, Rodrigues Manuel, Ray-Coquard Isabel |
|
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
|
Family history is significantly associated with prostate cancer and its early onset in Chinese population.
The Prostate 2019 Sep . Xu Yang, Huang Da, Wu Yishuo, Ye Dingwei, Zhang Ning, Gao Yi, Xu Danfeng, Na Rong, Xu Jianfe |
|
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization.
Lung cancer (Amsterdam, Netherlands) 2019 Sep 137 48-51. Kadouri Luna, Rottenberg Yakir, Zick Aviad, Hamburger Tamar, Lipson Doron, Peretz Tamar, Nechushtan Hov |
|
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
European urology 2019 Sep . Page Elizabeth C, Bancroft Elizabeth K, Brook Mark N, Assel Melissa, Hassan Al Battat Mona, Thomas Sarah, Taylor Natalie, Chamberlain Anthony, Pope Jennifer, Raghallaigh Holly Ni, Evans D Gareth, Rothwell Jeanette, Mahle Lovise, Grindedal Eli Marie M, James Paul, Mascarenhas Lyon, McKinley Joanne, Side Lucy, Thomas Tessy, van Asperen Christi, Vasen Hans, Kiemeney Lambertus A, Ringelberg Janneke, Jensen Thomas Dyrsø, Osther Palle J S, Helfand Brian T, Genova Elena, Oldenburg Rogier A, Cybulski Cezary, Wokolorczyk Dominika, Ong Kai-Ren, Huber Camilla, Lam Jimmy, Taylor Louise, Salinas Monica, Feliubadaló Lidia, Oosterwijk Jan C, van Zelst-Stams Wendy, Cook Jackie, Rosario Derek J, Domchek Susan, Powers Jacquelyn, Buys Saundra, O'Toole Karen, Ausems Margreet G E M, Schmutzler Rita K, Rhiem Kerstin, Izatt Louise, Tripathi Vishakha, Teixeira Manuel R, Cardoso Marta, Foulkes William D, Aprikian Armen, van Randeraad Heleen, Davidson Rosemarie, Longmuir Mark, Ruijs Mariëlle W G, Helderman van den Enden Apollonia T J M, Adank Muriel, Williams Rachel, Andrews Lesley, Murphy Declan G, Halliday Dorothy, Walker Lisa, Liljegren Annelie, Carlsson Stefan, Azzabi Ashraf, Jobson Irene, Morton Catherine, Shackleton Kylie, Snape Katie, Hanson Helen, Harris Marion, Tischkowitz Marc, Taylor Amy, Kirk Judy, Susman Rachel, Chen-Shtoyerman Rakefet, Spigelman Allan, Pachter Nicholas, Ahmed Munaza, Ramon Y Cajal Teresa, Zgajnar Janez, Brewer Carole, Gadea Neus, Brady Angela F, van Os Theo, Gallagher David, Johannsson Oskar, Donaldson Alan, Barwell Julian, Nicolai Nicola, Friedman Eitan, Obeid Elias, Greenhalgh Lynn, Murthy Vedang, Copakova Lucia, Saya Sibel, McGrath John, Cooke Peter, Rønlund Karina, Richardson Kate, Henderson Alex, Teo Soo H, Arun Banu, Kast Karin, Dias Alexander, Aaronson Neil K, Ardern-Jones Audrey, Bangma Chris H, Castro Elena, Dearnaley David, Eccles Diana M, Tricker Karen, Eyfjord Jorunn, Falconer Alison, Foster Christopher, Gronberg Henrik, Hamdy Freddie C, Stefansdottir Vigdis, Khoo Vincent, Lindeman Geoffrey J, Lubinski Jan, Axcrona Karol, Mikropoulos Christos, Mitra Anita, Moynihan Clare, Rennert Gadi, Suri Mohnish, Wilson Penny, Dudderidge Tim, , Offman Judith, Kote-Jarai Zsofia, Vickers Andrew, Lilja Hans, Eeles Rosalind |
|
Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification.
Cancer genetics 2019 Sep 237 90-96. Papamentzelopoulou Myrto, Apostolou Paraskevi, Fostira Florentia, Dimitrakakis Constantine, Loutradis Dimitris, Fountzilas George, Yannoukakos Drakoulis, Konstantopoulou Ire |
|
Exposure-response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients.
Cancer chemotherapy and pharmacology 2019 Aug . Nuthalapati Silpa, Stodtmann Sven, Shepherd Stacie Peacock, Ratajczak Christine K, Mensing Sven, Menon Rajeev, Xiong H |
|
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
|
Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
Clinical breast cancer 2019 Aug . Fountzilas Elena, Konstantopoulou Irene, Vagena Andromahi, Apostolou Paraskevi, Papadimitriou Christos, Christodoulou Christos, Tryfonopoulos Dimitrios, Manousou Kyriaki, Delimitsou Angeliki, Papamentzelopoulou Myrto, Fountzilas Georgios, Yannoukakos Drakoulis, Fostira Florent |
|
Prevalence of genetic susceptibility for breast and ovarian cancer in a non-cancer related study population: secondary germline findings from a Swiss single centre cohort.
Swiss medical weekly 2019 Aug 149 w20092. Kraemer Dennis, Azzarello-Burri Silvia, Steindl Katharina, Boonsawat Paranchai, Zweier Markus, Dedes Konstantin J, Joset Pascal, Fink Daniel, Rauch Ani |
|
Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
Annals of surgical oncology 2019 Aug . Park Ko Un, Weiss Anna, Rosso Kelly, Yi Min, Hunt Kelly, Kuerer Henry, Hanson Summer E, Candelaria Rosalind, Tevis Sarah, Thompson Alasta |
|
Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
BMC cancer 2019 Jul 19 (1): 722. Zayas-Villanueva Omar Alejandro, Campos-Acevedo Luis Daniel, Lugo-Trampe José de Jesús, Hernández-Barajas David, González-Guerrero Juan Francisco, Noriega-Iriondo María Fernanda, Ramírez-Sánchez Ilse Alejandra, Martínez-de-Villarreal Laura El |
|
Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
BMC cancer 2019 Jul 19 (1): 695. Danzinger Sabine, Tan Yen Yen, Rudas Margaretha, Kastner Marie-Theres, Weingartshofer Sigrid, Muhr Daniela, Singer Christian |
|
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
European urology oncology 2019 Jul . Chandrasekar Thenappan, Gross Laura, Gomella Leonard G, Hegarty Sarah E, Leong Joon Yau, Giri Veda |
|
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2019 Jul . Heemskerk-Gerritsen Bernadette A M, Jager Agnes, Koppert Linetta B, Obdeijn A Inge-Marie, Collée Margriet, Meijers-Heijboer Hanne E J, Jenner Denise J, Oldenburg Hester S A, van Engelen Klaartje, de Vries Jakob, van Asperen Christi J, Devilee Peter, Blok Marinus J, Kets C Marleen, Ausems Margreet G E M, Seynaeve Caroline, Rookus Matti A, Hooning Maartje |
|
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2019 Jul . Bernstein-Molho Rinat, Barnes-Kedar Inbal, Ludman Mark D, Reznik Gili, Feldman Hagit Baris, Samra Nadra Nasser, Eilat Avital, Peretz Tamar, Peretz Lilach Peled, Shapira Tamar, Magal Nurit, Kalis Marina Lifshitc, Yerushalmi Rinat, Vinkler Chana, Liberman Sari, Basel-Salmon Lina, Shohat Mordechai, Levy-Lahad Ephrat, Friedman Eitan, Bazak Lily, Goldberg Ya |
|
BRCA mutation characteristics in a series of index cases of breast cancer selected independent of family history.
The breast journal 2019 Jun . Bisgin Atil, Boga Ibrahim, Yalav Orcun, Sonmezler Ozge, Tug Bozdogan Sevc |
|
Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers.
JNCI cancer spectrum 2019 Jun 3 (2): pkz028. Yost Shawn, Ruark Elise, Alexandrov Ludmil B, Rahman Nazne |
|
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
|
The Spectrum of Mutations Predisposing to Familial Breast Cancer in Poland.
International journal of cancer 2019 Jun . Cybulski Cezary, Kluzniak Wojciech, Huzarski Tomasz, Wokolorczyk Dominika, Kashyap Aniruddh, Rusak Bogna, Stempa Klaudia, Gronwald Jacek, Szymiczek Agata, Bagherzadeh Maryam, Jakubowska Anna, Debniak Tadeusz, Lener Marcin, Rudnicka Helena, Szwiec Marek, Jarkiewicz-Tretyn Joanna, Stawicka Malgorzata, Domagala Pawel, Narod Steven A, Lubinski Jan, Akbari Mohammad R, |
|
Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Clinical breast cancer 2019 May . Zhou Yunyun, Simmons Josh, Jordan Christina D, Sonbol Mohamad Bassam, Maihle Nita, Tang Shou-Chi |
|
Assessment of PARP4 as a candidate breast cancer susceptibility gene.
Breast cancer research and treatment 2019 May . Prawira Aldo, Munusamy Prabhakaran, Yuan Jimin, Chan Claire Hian Tzer, Koh Geok Ling, Shuen Timothy Wai Ho, Hu Jiancheng, Yap Yoon Sim, Tan Min Han, Ang Peter, Lee Ann Siew G |
|
Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.
Breast cancer (Tokyo, Japan) 2019 May 26 (3): 365-372. Abbas Saba, Siddique Ayesha, Shahid Naeem, Khan Rabbia Tariq, Fatima War |
|
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients.
Clinical pharmacokinetics 2019 May 58 (5): 615-625. Zhou Diansong, Li Jianguo, Bui Khanh, Learoyd Maria, Berges Alienor, Milenkova Tsveta, Al-Huniti Nidal, Tomkinson Helen, Xu Hongm |
|
Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
International journal of clinical oncology 2019 May . Nomura Hidetaka, Sekine Masayuki, Yokoyama Shiro, Arai Masami, Enomoto Takayuki, Takeshima Nobuhiro, Nakamura Sei |
|
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
Journal of ovarian research 2019 May 12 (1): 40. Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa |
|
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
BMC cancer 2019 May 19 (1): 422. da Costa Alexandre A B A, do Canto Luisa M, Larsen Simon Jonas, Ribeiro Adriana Regina Gonçalves, Stecca Carlos Eduardo, Petersen Annabeth Høgh, Aagaard Mads M, de Brot Louise, Baumbach Jan, Baiocchi Glauco, Achatz Maria Isabel, Rogatto Silvia Regi |
|
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Gynecologic oncology 2019 May . Tomao Federica, Musacchio Lucia, Di Mauro Federica, Boccia Serena Maria, Di Donato Violante, Giancotti Antonella, Perniola Giorgia, Palaia Innocenza, Muzii Ludovico, Benedetti Panici Pierlui |
|
Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms.
Breast cancer research and treatment 2019 Apr . Bernstein-Molho Rinat, Singer Amihood, Laitman Yael, Netzer Iris, Zalmanoviz Shelley, Friedman Eit |
|
Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients.
Cancer medicine 2019 Mar . Singer Christian F, Tan Yen Y, Muhr Daniela, Rappaport Christine, Gschwantler-Kaulich Daphne, Grimm Christoph, Polterauer Stephan, Pfeiler Georg, Berger Andreas, Tea Muy-Kheng |
|
Exploring genetic counselors' perceptions of usefulness and intentions to use refined risk models in clinical care based on the Technology Acceptance Model (TAM).
Journal of genetic counseling 2019 Mar . Heinlen Christopher, Hovick Shelly R, Brock Guy N, Klamer Brett G, Toland Amanda Ewart, Senter Leig |
|
Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.
Journal of medical biochemistry 2019 Mar 38 (1): 13-21. Alyahri Nora, Abdi Saba, Khan Wajahatullah, Elrobh Mohamed, Addar Mohammed H, Babay Zeneb A, Alanazi Mohamed, Aldaihan Sooad, Shaik Jilani, Arafah Maha, Parine Narasimha Reddy, Warsy Arjuma |
|
Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
International journal of cancer 2019 Mar . Feliubadaló Lídia, López-Fernández Adrià, Pineda Marta, Díez Orland, Del Valle Jesús, Gutiérrez-Enríquez Sara, Teulé Alex, González Sara, Stjepanovic Neda, Salinas Mónica, Capellá Gabriel, Brunet Joan, Lázaro Conxi, Balmaña Judith, |
|
Prevalence of BRCA mutations among hereditary breast and/or ovarian cancer patients in Arab countries: systematic review and meta-analysis.
BMC cancer 2019 Mar 19 (1): 256. Abdulrashid Khadiga, AlHussaini Nour, Ahmed Wifag, Thalib Lukm |
|
Prevalence, spectrum and founder effect of BRCA1 and BRCA2 mutations in Epithelial Ovarian Cancer from Middle East.
Human mutation 2019 Mar . Siraj Abdul K, Bu Rong, Iqbal Kaleem, Siraj Nabil, Al-Haqawi Wael, Al-Badawi Ismail A, Parvathareddy Sandeep Kumar, Masoodi Tariq, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla |
|
The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis.
The Prostate 2019 Mar . Oh Mok, Alkhushaym Nasser, Fallatah Saad, Althaghfi Abdulhamid, Aljadeed Rana, Alsowaida Yazed, Jeter Joanne, Martin Jennifer R, Babiker Hani M, McBride Ali, Abraham I |
|
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.
Cancer 2019 Mar 125 (5): 698-703. Laitman Yael, Michaelson-Cohen Rachel, Levi Einat, Chen-Shtoyerman Rakefet, Reish Orit, Josefsberg Ben-Yehoshua Sagi, Bernstein-Molho Rinat, Keinan-Boker Lital, Rosengarten Ora, Silverman Barbara G, Perri Tamar, Korach Jacob, Mor Pnina, Ephrat Ben-Baruch Noa, Levy Lahad Ephrat, Friedman Eitan, |
|
Oncology letters 2019 Feb 17 (2): 1986-1995. Huszno Joanna, Kolosza Zofia, Grzybowska E |
|
BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.
Cancer letters 2019 Feb . Solinas Cinzia, Marcoux Diane, Garaud Soizic, Vitória Joel Rodrigues, Van den Eynden Gert, de Wind Alexandre, De Silva Pushpamali, Boisson Anais, Craciun Ligia, Larsimont Denis, Piccart-Gebhart Martine, Detours Vincent, Roodenbeke Daphné t'Kint de, Willard-Gallo Kar |
|
BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Pathology oncology research : POR 2019 Feb . Mehemmai Chiraz, Cherbal Farid, Hamdi Yosr, Guedioura Abdelmoumene, Benbrahim Wassila, Bakour Rabah, Abdelhak Son |
|
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.
Breast cancer research and treatment 2019 Feb . Kotsopoulos Joanne, Lubinski Jan, Lynch Henry T, Tung Nadine, Armel Susan, Senter Leigha, Singer Christian F, Fruscio Robert, Couch Fergus, Weitzel Jeffrey N, Karlan Beth, Foulkes William D, Moller Pal, Eisen Andrea, Ainsworth Peter, Neuhausen Susan L, Olopade Olufunmilayo, Sun Ping, Gronwald Jacek, Narod Steven A, |
|
Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
Breast cancer research and treatment 2019 Feb . Lan Yujia, Zhao Erjie, Luo Shangyi, Xiao Yun, Li Xia, Cheng Shuj |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
Breast cancer research and treatment 2019 Jan . Pilewskie Melissa, Zabor Emily C, Gilbert Elizabeth, Stempel Michelle, Petruolo Oriana, Mangino Debra, Robson Mark, Jochelson Maxine |
|
Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Human genomics 2019 Jan 13 (1): 4. Yi Dandan, Xu Lei, Luo Jiaqi, You Xiaobin, Huang Tao, Zi Yi, Li Xiaoting, Wang Ru, Zhong Zaixuan, Tang Xiaoqiao, Li Ang, Shi Yujian, Rao Jianmei, Zhang Yifen, Sang Jianfe |
|
Germline variation in BRCA1/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
International journal of cancer 2019 Jan . Bhaskaran Shanmuga Priya, Chandratre Khyati, Gupta Hemant, Zhang Li, Wang Xiaoyu, Cui Jian, Kim Yeong C, Sinha Siddharth, Jiang Luhan, Lu Boya, Wu Xiaobing, Qin Zixin, Huang Teng, Wang San Mi |
|
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
Breast cancer research and treatment 2019 Jan 173 (2): 385-395. Ryu Jai Min, Choi Hee Jun, Kim Isaac, Nam Seok Jin, Kim Seok Won, Yu Jonghan, Lee Se Kyung, Choi Doo Ho, Park Yeon Hee, Kim Jong-Won, Seo Jeong-Sun, Park Jung-Hoon, Lee Jeong Eon, Kim Sung-Won, |
|
Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32 (Supplementum2): 72-78. Soukupová Jana, Lhotová Klára, Zemánková Petra, Vocka Michal, Janatová Markéta, Stolarová Lenka, Borecká Marianna, Kleiblová Petra, Machácková Eva, Foretová Lenka, Koudová Monika, Lhota Filip, Tavandzis Spiros, Zikán Michal, Stránecký Viktor, Veselá Kamila, Panczak Aleš, Kotlas Jaroslav, Kleibl Zden |
|
Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Genes 2019 09 10 (9): . Dugo Matteo, Devecchi Andrea, De Cecco Loris, Cecchin Erika, Mezzanzanica Delia, Sensi Marialuisa, Bagnoli Mari |
|
Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
Melanoma research 2019 06 29 (3): 248-253. Sarubi Helena C, Pereira Núbia B, Gomes Carolina C, Gomez Ricardo S, Carmo Ana C M, Melo Flavia M, Bastos-Rodrigues Luciana, Pedrosa Moisés S, Friedman Eitan, De Marco Lu |
|
Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
BMC cancer 2018 Dec 18 (1): 1253. Lin Zhenyu, Liu Junli, Peng Li, Zhang Dejun, Jin Ming, Wang Jing, Xue Jun, Liu Hongli, Zhang T |
|
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis.
Critical reviews in oncology/hematology 2018 Dec 132 111-115. Marchetti C, De Felice F, Boccia S, Sassu C, Di Donato V, Perniola G, Palaia I, Monti M, Muzii L, Tombolini V, Benedetti Panici |
|
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
Journal of the National Cancer Institute 2018 Nov 110 (11): 1178-1189. Oh Mok, McBride Ali, Yun Seongseok, Bhattacharjee Sandipan, Slack Marion, Martin Jennifer R, Jeter Joanne, Abraham I |
|
Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.
BMC cancer 2018 Oct 18 (1): 1039. Arora Nimisha, Talhouk Aline, McAlpine Jessica N, Law Michael R, Hanley Gillian |
|
Clinical outcomes of adolescents and young adults with advanced solid tumours participating in phase I trials.
European journal of cancer (Oxford, England : 1990) 2018 Sep 101 55-61. Sundar Raghav, McVeigh Terri, Dolling David, Petruckevitch Ann, Diamantis Nikolaos, Ang Joo Ern, Chenard-Poiriér Maxime, Collins Dearbhaile, Lim Joline, Ameratunga Malaka, Khan Khurum, Kaye Stan B, Banerji Udai, Lopez Juanita, George Angela J, de Bono Johann S, van der Graaf Winette |
|
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
International journal of cancer 2018 Sep . Li Jingmei, Wen Wei Xiong, Eklund Martin, Kvist Anders, Eriksson Mikael, Christensen Helene Nordahl, Torstensson Astrid, Bajalica-Lagercrantz Svetlana, Dunning Alison M, Decker Brennan, Allen Jamie, Luccarini Craig, Pooley Karen, Simard Jacques, Dorling Leila, Easton Douglas F, Teo Soo-Hwang, Hall Per, Borg Åke, Grönberg Henrik, Czene Kami |
|
Psychosocial Impact of BRCA Testing in Young Black Breast Cancer Survivors.
Psycho-oncology 2018 Sep . Gonzalez Brian D, Hoogland Aasha I, Kasting Monica L, Cragun Deborah, Kim Jongphil, Ashing Kimlin, Holt Cheryl L, Hughes Halbert Chanita, Pal Tuya, Vadaparampil Susan |
|
A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.
Breast cancer research and treatment 2018 Aug . de Souza Timoteo Ana Rafaela, Gonçalves Ana Élida Menezes Magalhães, Sales Lucas Amadeus Porpino, Albuquerque Betina Menezes, de Souza Jorge Estefano Santana, de Moura Patrícia Cristina Pascoto, de Aquino Marcos Alberto Arruda, Agnez-Lima Lucymara Fassarela, Lajus Tirzah Braz Pet |
|
Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel.
Anticancer research 2018 Aug 38 (8): 4557-4563. Kenan Efrat Schwarz, Friger Michael, Shochat-Bigon Daphna, Schayek Hagit, Bernstein-Molho Rinat, Friedman Eit |
|
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA oncology 2018 Aug . Lu Hsiao-Mei, Li Shuwei, Black Mary Helen, Lee Shela, Hoiness Robert, Wu Sitao, Mu Wenbo, Huether Robert, Chen Jefferey, Sridhar Srijani, Tian Yuan, McFarland Rachel, Dolinsky Jill, Tippin Davis Brigette, Mexal Sharon, Dunlop Charles, Elliott Aar |
|
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Gynecologic oncology 2018 Aug . Li Ang, Xie Rong, Zhi Qihuan, Deng Yixiao, Wu Yangming, Li Weiwei, Yang Lu, Jiao Zinan, Luo Jiaqi, Zi Yi, Sun Gang, Zhang Jiajia, Shi Yujian, Liu Ji |
|
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Breast cancer research and treatment 2018 Aug 171 (1): 85-94. Wunderle Marius, Gass Paul, Häberle Lothar, Flesch Vivien M, Rauh Claudia, Bani Mayada R, Hack Carolin C, Schrauder Michael G, Jud Sebastian M, Emons Julius, Erber Ramona, Ekici Arif B, Hoyer Juliane, Vasileiou Georgia, Kraus Cornelia, Reis Andre, Hartmann Arndt, Lux Michael P, Beckmann Matthias W, Fasching Peter A, Hein Alexand |
|
Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer.
Journal of global oncology 2018 Aug (4): 1-9. Abulkhair Omalkhair, Al Balwi Mohammed, Makram Ola, Alsubaie Lamia, Faris Medhat, Shehata Hussam, Hashim Ahmed, Arun Banu, Saadeddin Ahmed, Ibrahim Ezzeld |
|
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast cancer research and treatment 2018 Jul 170 (1): 101-109. Clifton Katherine, Gutierrez-Barrera Angelica, Ma Junsheng, Bassett Roland, Litton Jennifer, Kuerer Henry, Moulder Stacy, Albarracin Constance, Hortobagyi Gabriel, Arun Ba |
|
Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
The Journal of molecular diagnostics : JMD 2018 Jul . Vendrell Julie A, Vilquin Paul, Larrieux Marion, Van Goethem Charles, Solassol Jérô |
|
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management.
The breast journal 2018 Jul . Loi Mauro, Desideri Isacco, Olmetto Emanuela, Francolini Giulio, Greto Daniela, Bonomo Pierluigi, Simontacchi Gabriele, Di Brina Lucia, Meattini Icro, Livi Loren |
|
Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.
Japanese journal of clinical oncology 2018 Jul . Sakurada Shoko, Watanabe Yoh, Tokunaga Hideki, Takahashi Fumiaki, Yamada Hidekazu, Takehara Kazuhiro, Yaegashi Nob |
|
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 Jul 47 (5): 2088-2096. Shi Tingyan, Wang Pan, Tang Wenbin, Jiang Rong, Yin Sheng, Shi Di, Wang Qing, Wei Qingyi, Zang Rong |
|
Comparison of background parenchymal enhancement and fibroglandular density at breast magnetic resonance imaging between BRCA gene mutation carriers and non-carriers.
Clinical imaging 2018 Jun 51 347-351. Grubstein Ahuva, Rapson Yael, Benzaquen Oshra, Rozenblatt Shira, Gadiel Itay, Atar Eli, Yerushalmi Rinat, Cohen Matan |
- Page last reviewed:Mar 16, 2019
- Page last updated:Aug 05, 2020
- Content source: